Your session is about to expire
← Back to Search
Behavioral Intervention
CBT for HIV with Mental Health Issues (Synk2b Trial)
N/A
Waitlist Available
Led By Steven A Safren, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Group 1: (Men who have sex with men (MSM) who have used stimulants within the past 4 months (approximately 10 participants))OR Group 2: transgender women (approximately 10 participants) OR Group 3: Emerging adults between the ages of 18 and 26 (inclusive; approximately 10 participants)
Age: 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
Synk2b Trial Summary
This trial is testing different ways to help people with HIV manage their treatment and mental health/substance use.
Who is the study for?
This trial is for HIV-positive adults with uncontrolled virus levels in the past year. It includes men who have sex with men (MSM) using stimulants, transgender women, and young adults aged 18-26. Participants must not be severely ill or impaired at consent time, nor currently/recently in CBT treatment.Check my eligibility
What is being tested?
The study tests Cognitive Behavioral Therapy (CBT) tailored to address both mental health issues and medication adherence among people living with HIV. The goal is to improve their ability to manage HIV treatment alongside coping with psychological and substance use challenges.See study design
What are the potential side effects?
While CBT generally does not cause physical side effects, participants may experience emotional discomfort discussing personal issues during therapy sessions. Increased stress or anxiety can occur when confronting difficult topics.
Synk2b Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
The study is looking for three specific groups of people: (1) men who have sex with men and have used stimulants in the past 4 months, (2) transgender women, and (3) young adults between the ages of 18 and 26.
Select...
I am 18 years old or older.
Synk2b Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of participants who completes the follow up assessment
Secondary outcome measures
ART Medication Adherence
Percentage of participants with improvement in syndemic, behavioral health outcomes
Percentage of participants with undetectable viral load
Synk2b Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors GroupExperimental Treatment1 Intervention
Participants in this group will receive the CBT for Syndemics and Adherence Factors intervention for a total of 14 sessions over 4 months.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
897 Previous Clinical Trials
409,185 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,447 Previous Clinical Trials
2,593,991 Total Patients Enrolled
Steven A Safren, PhDPrincipal InvestigatorUniversity of Miami
3 Previous Clinical Trials
796 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a severe mental illness that is not being treated and could affect your ability to take part in the study.The study is looking for three specific groups of people: (1) men who have sex with men and have used stimulants in the past 4 months, (2) transgender women, and (3) young adults between the ages of 18 and 26.I am currently in cognitive behavioral therapy or completed it within the last year.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the public have access to this experiment at present?
"According to the information posted on clinicaltrials.gov, this particular trial is not presently enrolling patients. This investigation was initially put up for recruitment in August of 2022 and last updated at the end October of that same year. Despite this study no longer being open, there are 127 other trials recruiting participants currently active research opportunities."
Answered by AI
Share this study with friends
Copy Link
Messenger